Glimepiride as insulin sensitizer: Increased liver and muscle responses to insulin

Diabetes, Obesity and Metabolism

Volumn 10, Issue 7, 2008, Pages 596-600

  Mori, R C T ^a   Hirabara, S M ^a   Hirata, A E ^b   Okamoto, M M ^a   Machado, Ubirratan F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOHULIN; GLIMEPIRIDE; GLUCOSE; GLUCOSE TRANSPORTER 4; GLUTAMATE SODIUM; GLYCOGEN; GLYCOGEN SYNTHASE KINASE; INSULIN; INSULIN SENSITIZING AGENT; LIVER ENZYME; OXIDOREDUCTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GLYCEMIC CONTROL; GLYCOGEN ANALYSIS; GLYCOGEN SYNTHESIS; IN VITRO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIVER; MALE; NONHUMAN; OBESITY; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE;

EID: 45449113177     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2008.00870.x     Document Type: Article

References (12)

1. Reaven GM. The metabolic syndrome: Is this diagnosis necessary? Am J Clin Nutr 2006; 83: 1237-1247.
2. Dohm GL, Elton CW, Friedman JE et al. Decreased expression of glucose transporter in muscle from insulin-resistant patients. Am J Physiol 1991; 260: E459-E463.
3. de Carvalho Papa P, Vargas AM, Silva JLT, Nunes MT, Machado UF. GLUT4 protein is differently modulated during development of obesity in monosodium glutamate-treated mice. Life Sci 2002; 71: 1917-1928.
4. Müller G. The molecular mechanism of the insulin mimetic/ sensitizing activity of the antidiabetic sulfonylurea drug Amaryl. Mol Med 2000; 6: 907-933.
5. Mitsumoto Y, Klip A. Developmental regulation of the subcellular distribution and glycosylation of GLUT1 and GLUT4 glucose transporters during myogenesis of L6 muscle cells. J Biol Chem 1992; 267: 4957-4962.
6. Zanquetta MM, Nascimento MEC, Mori RCT, D'Agord Schaan B, Young M, Machado UF. Participation of β-adrenergic modulation of GLUT4 expression during fasting and refeeding in rats. Metabolism 2006; 55: 1538-1545.
7. Crettaz M, Prentki M, Zaninetti D, Jeanrenaud B. Insulin resistance in soleus muscle from obese Zucker rats. Involvement of several defective sites. Biochem J 1980; 186: 525-534.
8. Geary N, Langhans W, Scharrer E. Metabolic concomitants of glucagon-induced suppression of feeding in the rat. Am J Physiol 1981; 241: R330-R335.
9. Papa PC, Seraphim PM, Machado UF. Loss of weight restores GLUT4 content in insulin-sensitive tissues of monosodium glutamate-treated mice. Int J Obes Relat Metab Disord 1997; 21: 1065-1070.
10. Kaku K, Inoue Y, Kaneko T. Extrapancreatic effects of sulfonylurea drugs. Diabetes Res Clin Pract 1995; 28: S105-S108.
11. Schiekofer S, Rudofsky Jr G, Andrassy M et al. Glimepiride reduces mononuclear activation of the redox-sensitive transcription nuclear factor-kappaB. Diabetes Obes Metab 2003; 5: 251-261.
12. Silva JLT, Giannocco G, Furuya DT et al. NF-κB, MEF-2A, MEF-2D and HIF1a involvement on insulin and contraction-induced regulation of GLUT4 gene expression in soleus muscle. Mol Cell Endocrinol 2005; 240: 82-93.